| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |





From the Department of Pharmacology and Therapeutics,* Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada; Canadian Institute for Health Research Group in Matrix Dynamics and Dental Research Institute,
University of Toronto, Toronto, Canada; the Department of Periodontology and Oral Pathology,
Dental School of Araraquara, State University of São Paulo, Araraquara, São Paulo, Brazil; the Department of Dermatology,
Ludwig Boltzman Institute for Immunobiology of the Skin, University Hospital, Muenster, Germany; and Drug Discovery,¶ Johnson and Johnson Pharmaceutical Research and Development, Spring House, Pennsylvania
We have investigated the specific contribution of protease-activated receptor-2 (PAR2) to host defense during Porphyromonas gingivalis infection. Culture supernatants from P. gingivalis strains 33277 and W50 provoked Ca2+ mobilization in cells transfected with PAR2 (PAR2-KNRK) and desensitized the subsequent responses to PAR2-selective agonist. In addition, culture supernatants of P. gingivalis E8 (RgpA/RgpB double knockout) did not cause calcium response in PAR2-KNRK cells, evidencing the involvement of the arginine-specific cysteine proteases RgpA and RgpB in PAR2 activation by P. gingivalis. Injection of P. gingivalis into mouse subcutaneous chambers provoked an increased proteolytic activity, which was inhibited by serine protease inhibitors. Fluids collected from chambers of P. gingivalis-injected mice were able to activate PAR2 and this activation was inhibited by serine protease inhibitors. P. gingivalis inoculation into subcutaneous chambers of wild-type mice induced an inflammatory response that was inhibited by a serine protease inhibitor and was significantly reduced in PAR2-deficient mice. Finally, mice orally challenged with P. gingivalis developed alveolar bone loss, which was significantly reduced in PAR2-deficient mice at 42 and 60 days after P. gingivalis infection. We conclude that PAR2 is activated on P. gingivalis infection, in which it plays an important role in the host inflammatory response.
This article has been cited by other articles:
![]() |
D. M. Wong, V. Tam, R. Lam, K. A. Walsh, L. Tatarczuch, C. N. Pagel, E. C. Reynolds, N. M. O'Brien-Simpson, E. J. Mackie, and R. N. Pike Protease-Activated Receptor 2 Has Pivotal Roles in Cellular Mechanisms Involved in Experimental Periodontitis Infect. Immun., February 1, 2010; 78(2): 629 - 638. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Giacaman, A. C. Asrani, K. F. Ross, and M. C. Herzberg Cleavage of protease-activated receptors on an immortalized oral epithelial cell line by Porphyromonas gingivalis gingipains Microbiology, October 1, 2009; 155(10): 3238 - 3246. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Khoufache, F. LeBouder, E. Morello, F. Laurent, S. Riffault, P. Andrade-Gordon, S. Boullier, P. Rousset, N. Vergnolle, and B. Riteau Protective Role for Protease-Activated Receptor-2 against Influenza Virus Pathogenesis via an IFN-{gamma}-Dependent Pathway J. Immunol., June 15, 2009; 182(12): 7795 - 7802. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rallabhandi, Q. M. Nhu, V. Y. Toshchakov, W. Piao, A. E. Medvedev, M. D. Hollenberg, A. Fasano, and S. N. Vogel Analysis of Proteinase-activated Receptor 2 and TLR4 Signal Transduction: A NOVEL PARADIGM FOR RECEPTOR COOPERATIVITY J. Biol. Chem., September 5, 2008; 283(36): 24314 - 24325. [Abstract] [Full Text] [PDF] |
||||
![]() |
E Hyun, P Andrade-Gordon, M Steinhoff, and N Vergnolle Protease-activated receptor-2 activation: a major actor in intestinal inflammation Gut, September 1, 2008; 57(9): 1222 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. J. Moraes, R. Martin, J. D. Plumb, E. Vachon, C. M. Cameron, A. Danesh, D. J. Kelvin, W. Ruf, and G. P. Downey Role of PAR2 in murine pulmonary pseudomonal infection Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L368 - L377. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dommisch, W. O. Chung, M. G. Rohani, D. Williams, M. Rangarajan, M. A. Curtis, and B. A. Dale Protease-Activated Receptor 2 Mediates Human Beta-Defensin 2 and CC Chemokine Ligand 20 mRNA Expression in Response to Proteases Secreted by Porphyromonas gingivalis Infect. Immun., September 1, 2007; 75(9): 4326 - 4333. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Giacaman, A. H. Nobbs, K. F. Ross, and M. C. Herzberg Porphyromonas gingivalis Selectively Up-Regulates the HIV-1 Coreceptor CCR5 in Oral Keratinocytes J. Immunol., August 15, 2007; 179(4): 2542 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yin and B. A. Dale Activation of protective responses in oral epithelial cells by Fusobacterium nucleatum and human {beta}-defensin-2 J. Med. Microbiol., July 1, 2007; 56(7): 976 - 987. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |